Field Guide to Psychiatric Assessment and Treatment

by Bauer, Mark S.

• ISBN13: 9780781737586
• ISBN10: 0781737583
• Edition: 1st
• Format: Paperback
• Copyright: 2003-05-09
• Publisher: LWW

Summary

Field Guide to Psychiatric Assessment and Treatment is an invaluable diagnostic guide for the non-specialist practitioner. Covering the fundamentals of psychiatric assessment and treatment, the guide is structured to allow practitioners to quickly and accurately diagnose adult psychiatric illnesses. In the first section, decision trees help practitioners work from a typical presenting complaint through a differential diagnosis. Cross-references conveniently link diagnostic criteria to more detailed information on the individual disorders found in the second section. The guide provides treatment options commonly used in a primary care setting, while clearly highlighting when a practitioner should make a referral to a specialist.

Table of Contents

Preface	xiii
How to Use This Field Guide	xv
Acknowledgments	xix
Section I. The Biopsychosocial Assessment and How to Get There Efficiently	1	(14)
Section II. Symptom-Driven Interviewing	15	(145)
Introduction	15	(2)
Depression or Fatigue	17	(7)
Manic Symptoms	24	(4)
Anxiety/Nervousness	28	(8)
Psychosis (Hallucinations and Delusions)	36	(9)
Substance Use and Gambling	45	(10)
Suicidality and Assaultiveness (Including Acute Management Strategies)	55	(12)
Change in Mental Status/Delirium	67	(7)
Problems with Memory or Organization	74	(10)
Problems with Concentration, Impulsivity, and Irritability	84	(2)
Eating and Appearance	86	(5)
Sleep Problems	91	(9)
Sexual Problems	100	(13)
Chronic Pain and Its Management in ``The House of Pain''	113	(10)
Multiple Unexplained Physical Complaints	123	(7)
Relationship and Personal Problems	130	(6)
Competency	136	(7)
Assessment and Management of Psychotropic-Induced Movement Disorders	143	(15)
When the Black Dog Comes Back: Thinking Through Recurrence	158	(2)
Section III. Disorders	160	(85)
Introduction	160	(4)
Mood Disorders	164	(1)
Major Depressive Disorder	164	(3)
Dysthymic Disorder	167	(2)
Manic-Depressive (Bipolar) Disorder	169	(4)
Type I	169	(1)
Type II	169	(4)
Cyclothymic Disorder	173	(1)
Anxiety Disorders	174	(1)
Panic Disorder	174	(3)
Phobias	177	(3)
Specific Phobia	177	(1)
Social Phobia	177	(1)
Agoraphobia	177	(3)
Generalized Anxiety Disorder	180	(2)
Obsessive-Compulsive Disorder	182	(2)
Posttraumatic Stress Disorder	184	(3)
Acute Stress Disorder	187	(2)
Substance Use Disorders and Pathological Gambling	189	(1)
Dependence	189	(1)
Abuse	189	(6)
Specific Substances:	195	(1)
Alcohol
Amphetamines
Caffeine
Cannabis
Cocaine/Crack
Hallucinogens
Inhalants
Nicotine
Opioids
Phencyclidine
Sedatives, Hypnotics, or Anxiolytics
Ecstasy and Related Compounds
Pathological Gambling	196	(1)
Schizophrenia and Other Psychotic Disorders	197	(1)
Schizophrenia	197	(4)
Schizoaffective Disorder	201	(2)
Delusional Disorder	203	(1)
Adjustment Disorders	204	(2)
Cognitive Disorders	206	(1)
Dementia	206	(2)
Attention-Deficit/Hyperactivity Disorder	208	(2)
Somatoform and Related Disorders	210	(1)
Somatization Disorder	210	(2)
Pain Disorder	212	(2)
Hypochondriasis	214	(1)
Conversion Disorder	215	(2)
Factitious Disorder and Malingering Disorder	217	(1)
Body Dysmorphic Disorder	218	(2)
Eating Disorders	220	(1)
Anorexia Nervosa	220	(1)
Bulimia Nervosa	221	(2)
Sleep Disorders	223	(5)
Sexual and Gender Identity Disorders	228	(4)
Premenstrual Dysphoric Disorder	232	(2)
Dissociative Disorders	234	(2)
Personality Disorders	236	(9)
Section IV. Treatment	245	(92)
Introduction	245	(7)
Psychotherapy: Supportive Psychotherapy Techniques and Referral Information for Formal, Disorder-Specific Psychotherapies	252	(10)
Outline of Supportive Psychotherapy	252	(5)
Disorder-Specific Psychotherapies	257	(5)
Medications	262	(1)
Antidepressants	262	(1)
Tricyclics	262	(11)
Amitriptyline	262	(2)
Clomipramine	264	(1)
Desipramine	265	(2)
Doxepin	267	(1)
Imipramine	268	(2)
Nortriptyline	270	(1)
Protriptyline	271	(2)
Selective Serotonin Reuptake Inhibitors	273	(7)
Citalopram	273	(1)
Escitalopram Oxalate	274	(1)
Fluoxetine	275	(1)
Fluvoxamine	276	(2)
Paroxetine	278	(1)
Sertraline	279	(1)
Monoamine Oxidase Inhibitors	280	(3)
Phenelzine	280	(2)
Tranylcypromine	282	(1)
Other Antidepressants	283	(5)
Bupropion	283	(1)
Mirtazapine	284	(1)
Nefazodone	285	(1)
Trazodone	286	(1)
Venlafaxine	287	(1)
Antimanics and Putative Mood Stabilizers	288	(9)
Carbamazepine	288	(2)
Lamotrigine	290	(1)
Lithium	291	(2)
Oxcarbazepine	293	(1)
Topiramate	294	(1)
Valproate	295	(1)
Verapamil	296	(1)
Adjuvant Mood Disorder Agents	297	(3)
Levothyroxine (Thyroxine, L-Thyroxine)	297	(1)
Triiodothyronine (Liothyronine)	298	(2)
Antipsychotics/Neuroleptics	300	(1)
Typical Neuroleptics	300	(12)
Chlorpromazine	301	(1)
Fluphenazine	302	(1)
Haloperidol	303	(1)
Loxapine	304	(1)
Mesoridazine	305	(1)
Molindone	306	(1)
Perphenazine	307	(1)
Thioridazine	308	(2)
Thiothixene	310	(1)
Trifluoperazine	311	(1)
Atypical Neuroleptics	312	(5)
Clozapine	312	(1)
Olanzapine	313	(1)
Quetiapine	314	(1)
Risperidone	315	(1)
Ziprasidone	316	(1)
Benzodiazepines	317	(7)
Alprazolam	317	(1)
Chlordiazepoxide	318	(1)
Clonazepam	319	(1)
Diazepam	320	(1)
Lorazepam	321	(1)
Oxazepam	322	(1)
Temazepam	323	(1)
Triazolam	323	(1)
Nonbenzodiazepine Hypnotics	324	(2)
Zaleplon	324	(1)
Zolpidem	325	(1)
Other Agents Used in Anxiety Disorders	326	(3)
Buspirone (Generalized Anxiety Disorder)	326	(1)
Clonidine (PTSD)	327	(1)
Gabapentin (Anxiety Symptoms, Pain, Mood Stabilization)	328	(1)
Prazosin (PTSD)	329	(1)
Cognitive Enhancers	329	(3)
Donepezil	330	(1)
Galantamine	330	(1)
Rivastigmine	331	(1)
Tacrine	331	(1)
Stimulants	332	(3)
Methlyphenidate	332	(1)
Pemoline	333	(2)
Therapeutic Devices Used in Psychiatry	335	(2)
Electroconvulsive Therapy	335	(1)
Bright Visible Spectrum Light	336	(1)
Research Interventions	336	(1)
Appendices	337	(28)
Appendix 1: Cognitive Screening Instruments	337	(2)
Appendix 2: Alcohol and Benzodiazepine Detoxification Procedure: The Clinical Institute Withdrawal Assessment (CIWA) Protocol	339	(2)
Appendix 3: Barbiturate Detoxification and the Pentobarbital Challenge Test	341	(1)
Appendix 4: Opiate Detoxification Procedures	342	(1)
Appendix 5: Stimulant Detoxification Procedures	343	(1)
Appendix 6: Nicotine Detoxification Procedures	344	(1)
Appendix 7: Biopsychosocial Approach to Sleep Complaints	345	(2)
Appendix 8: Abnormal Involuntary Movements Scale (AIMS)	347	(2)
Appendix 9: Guide to Opiate Selection for Chronic Pain	349	(1)
Appendix 10: Some Self-Help Resources for Individuals Being Treated and Their Significant Others	350	(5)
Appendix 11: Psychotropic Drug Equivalency Tables	355	(3)
Appendix 12: Cytochrome P-450 Effects for Major Psychotropic Medications	358	(4)
Appendix 13: Dietary and Pharmacologic Substances Causing Adverse Interactions with Monoamine Oxidase Inhibitor (MAOI) Antidepressants	362	(1)
Appendix 14: Alternative and Complementary Agents Used for Psychiatric Symptoms	363	(2)
Key References: An Annotated Bibliography for Additional Clinically Relevant Information	365	(8)
Subject Index	373